Invasive mould disease (IMD) might affect up to a third of critically ill patients with COVID-19.
COVID-19-associated pulmonary aspergillosis (CAPA) is typically diagnosed on the basis of …

Background: Recent studies from multiple countries have shown a high prevalence of
coronavirus disease 2019 (COVID-19)-associated pulmonary aspergillosis (CAPA) among …

Our report of two critically ill patients suggests that IPA might be a relevant complication of
severe COVID-19 pneumonia in analogy to experiences in severe influenza pneumonia …

Background COVID‐19–associated pulmonary aspergillosis (CAPA) has emerged as an
invasive fungal disease, often affecting previously immunocompetent, mechanically …

Invasive fungal infections (IFIs) can complicate the clinical course of COVID-19 and are
associated with a significant increase in mortality, especially in critically ill patients admitted …

Objectives Information on the recently COVID‐19‐associated pulmonary aspergillosis
(CAPA) entity is scarce. We describe eight CAPA patients, compare them to colonised ICU …

Objectives The main objective of this study was to determine the incidence of invasive
pulmonary aspergillosis (IPA) in patients with coronavirus disease 2019 (COVID-19) …

There is increasing concern that patients with coronavirus disease 2019 (COVID-19) might
be at risk of developing invasive pulmonary aspergillosis co-infection. 1 In a cohort of 221 …

Reports of COVID‐19 associated pulmonary aspergillosis (CAPA) are rising, but the
associated mortality and factors affecting it are not well‐characterised. We performed a …

The aim of this study was to evaluate diagnostic means, host factors, delay of occurrence,
and outcome of patients with COVID-19 pneumonia and fungal coinfections in the intensive …